logo


22-01-2014

Porocel purchases Canadian catalyst plant and processing facility

Porocel of Canada, Ltd announces the acquisition of the Medicine Hat catalyst processing plant from Criterion Catalysts & Technologies Canada, Inc. Porocel of Canada, Ltd is a wholly-owned subsidiary of Porocel International, LLC.

The Medicine Hat facility will be Porocel’s fourth catalyst regeneration, rejuvenation and ex-situ presulphurization plant globally, adding to its other sites:  Lafayette (Louisiana), Luxembourg and Singapore. This acquisition strategically positions Porocel to service the growing Canadian catalyst market. The company will achieve growth with a focused, continued emphasis on HSE, and will be introducing new and innovative technologies tied to catalyst regeneration, rejuvenation, ex-situ presulphurization and other related catalyst processing technologies.

We look forward to having Medicine Hat in our portfolio, and to a safe & prosperous future operating in Canada.

Sponsor:

News Category:

Other News Items